<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 211 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page210.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=211">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 211 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 211</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=211"><img src="../thumb/211.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>176 / 2020-04                                                        Gastro-Intestinal Tract - 12.4.4
   Warnings and special precautions: Safety & effic. in childr.not   (S4) TABS, 41/11.4.3/1115, 1116  (S4) TABS, [P/S] 34/11.4.3/0006, 29/11.4.3/0123
   est., hepat.impairm., long-term safety in ren.& hepat.impairm.not   715312-001: 20 mg, 30, R126,43  892291-005: 20 mg, 28, R227,86
   est., excl.poss. malign.if gastr.ulc.suspect., monit.concom. warfar.&   715313-001: 40 mg, 30, R200,61  812153-006: 40 mg, 14, R169,52
   phenytoin, lact.intol., contains mannitol  Dosage: Take dly.dos.in the morn.  812153-014: 40 mg, 28, R339,05
   Interactions: Poss.interact.with drugs metabol. via cytochrome   Duod.ulc: 40 mg once dly. x2-4 wks.   (S4) IV INJ, [P/S] 33/11.4.3/0519
   P450 enzyme syst., elimin.of diazepam/warfar.& phenytoin prolong.,   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  707420-001: 40 mg/vial, 5 vials, R536,96
   digox. bioavail.incr., plasma conc.of omeprazole & clarithromycin incr.  Zollinger-Ellison syndr: Init.80 mg dly.thereaft. titrat.as necess.   Dosage: Inj.for IV use only over 2-15 mins.max. x7 days transf.then
   with concom.admin.           Admin.dly.dos above 80 mg in 2 div.dos.  to oral ther. Take dly.oral dos. in the morn.
                                Mild GORD: 20 mg/day x4-8 wks.  Duod.ulc: 40 mg once dly. x2-4 wks. Use in combinat. with appropr.
   ASPEN PANTOPRAZOLE, (Aspen Pharmacare: Pharma)   Long term/GORD relapse prevent: Recomm. maint: 20 mg/day   antibiot.when assoc.with H.Pylori.
   Pharmacare [P/S]             incr. to 40 mg/day in case of relapse. Reduc.to 20 mg dly aft.heal.  Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.
   Pantoprazole                 NSAID induc.gastro-duod.les.& dyspept. sympt. prev:   Zollinger-Ellison syndr: Init.80 mg dly. thereaft. titrat.as necess.
   Indications: Short-term treatm.of duod.& gastr. ulc.& reflux oe-  20 mg/day  Admin.dly.dos above 80 mg in 2 div.dos. If rapid acid control reqd.
   sophagit., duod.ulc.assoc.with H.pylori infect.in combinat.with ap-  Contraindications: Pregn.& lactat.& safety & effic.in childr.not est.,   admin init. 2x80 mg IV then transf.to oral ther as soon as clinic. justif.
   propr.antibiot., Zollinger-Ellison syndr.  sev.liv.funct.impairm., concom.atazanavir or nelfinavir  Mild gastro-oesophag.reflux dis: 20 mg/day x4 wks. An addit.4
   (S4) IV INJ, 42/11.4.3/0313  Side effects: Bld.dyscras., anaphylact.reacts.incl. anaphylact.shock,   wks.will usually achieve heal. if heal.insuffic.
   717247-001: 40 mg, 5x10 ml vials, R158,20  incr.liv.enzymes, elev. triglycerides, incr.body temp., depress., head-  Recurr.sympts.of heal.reflux dis: 20 mg once dly as on de-
   Dosage: IV use in pts.who cannot be treat.oral. Admin. over 2-15   aches, dizzin., vis. disturbs., GI disturbs., jaund.with/ without hepat.  mand regim.
   mins. Once reconstit.admin.by direct.IV or dil.furth.with 100 ml 0,9%   fail., allerg.reacts.incl.sev.skin reacts., photosens., arthralg., myalg.,   Long term managem.& relapse prev.in gastro-oesophag.re-
   NaCl or 5% gluc. only.       rhabdomyolys., bone fract., malaise, asthen., gynaecomast., impot.,   flux dis: Recomm.dos: 20 mg/day incr.to 40 mg/day if relapse oc-
   Duod.ulc: 40 mg once dly.x2-4 wks.incl.of oral use. Use in combinat.  Clostrid.diffic.assoc.diarrh., interstit. nephrit.  curs. Reduc.again to 20 mg when relapse heal.
   with appropr.antibiot.when assoc.with H.Pylori.  Warnings and special precautions: Excl.poss. malign., not to   Prev.of NSAID induc.gastroduod.les.& dyspept.sympts:
   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  exceed 20 mg dly in mild-mod.sev. liv.impairm., monit.liv.funct.in   Recomm.dos: 20 mg/day
   Zollinger-Ellison syndr: Init.80 mg dly theraft. titrat.up/ down as   pres.of impairm.& discont. if elev., restrict use for NSAID induc.effs.   Contraindications: Safety in pregn.& lactat.& safety & effic.in childr.
   need. Dos.above 80 mg to be div.& admin.2x dly. For rapid acid contr.  to pts.on cont. ther.& at incr.risk, not indicat.for mild GI complaints,   not est., sev.liv.funct. impairm., concom.atazanavir.
   start.dos.of 2 x 80 mg suffic. to decr.acid output to target range within   incr.risk of Clostrid.diffic. assoc. diarrh., confirm reflux oesophag.di-  Side effects: Leucopen., thrombocytopen., hypersens.reacts. incl.an-
   1 hr. Tfd.to oral formulat.as soon as clinic.justif.  agn.by endoscopy, incr.risk of SCLE and bone fract., poss. cyanoco-  aphylax.& sev.skin reacts., hyperlipidaem., lipid incr., weight changes,
   (S4) TABS, [P/S] 43/11.4.3/0545  balam malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.), hypomagnesaem.  sleep disords., depress., disorientat., headache, dizzin., vis.disturbs.,
   Indications: Symptomat.improvem.& heal.of mild GORD, long term   with prolong.treatm.  GI disturbs., dry mouth, rash, exanthema, erupt., prurit., urticar., an-
   managem.& prev.of GORD relapse.  Drug interactions: Poss.changes in absorpt.of pH-depend.meds.  gioed., arthralg., myalg.,asthen., fatig., malaise, incr.body temp., pe-
   717376-001: 20 mg, 30, R129,01  eg.ketoconazole, diazepam/ phenytoin & warfar.elimin.prolong., poss.   riph.oed., inj.site thrombophlebit., incr.liv enzym., hepatocellul. injur.,
   Dosage: Swallow whole. Recomm.dly.dos.in morn.bef./dur.breakf.  hypomagnesaem.with prolong.concom.digox.& tacrolim.,   jaund., hepatocell.fail., hallucinat., confus. esp.in pre-dispos./with
   Mild GORD: 20 mg/day.x4 wks.& if not suffic. heal. usuall.achiev.  pre-exist.sympts., interstit. nephrit., Stev.-John.syndr., Lyell syndr.,
   within furth.4 wks.          CORPOCID 20 mg, Activo [P/S]  erythema multiforme, photosens., C difficile assoc. diarrh.
   Long term managem.& prev.of GORD relapse: 20 mg/day incr.to   Omeprazole  Special precautions: Not indicat.for mild GI complaints.,furth.in-
   40 mg/day if relaps.occurs reduc. back to 20 mg/day aft.relaps.heal.  Indications: Duod.ulc.incl.relaps.prevent., gastr. ulc., reflux oe-  vestigat.if sympts.persist. despite adeq.treatm., not to exceed 40 mg
   (S4) TABS, [P/S] 43/11.4.3/0546  sophagit., Zollinger-Ellison syndr., NSAID-assoc.gastr./duod.ulc.,   dly in elderly/ren.funct.impairm., poss.incr.risk of C difficile-assoc.di-
   Indications: Short-term treatm.of duod.& gastr. ulc.& reflux oe-  H.pylori posit.duod. ulc.as part of eradic.program with appropr.  arrh.partic.in hospit.pts., monit. concom.anticoag.ther., excl.poss.ma-
   sophagit., duod.ulc.assoc.with H.pylori infect.in combinat.with ap-  antibiot.  lign., insuffic. clinic.data for long-term admin., not to exceed 20 mg dly
   propr.antibiot., Zollinger-Ellison syndr.  (S4) TABS, A 43/11.4.3/0502  in mild-mod.liv.impairm., monit. liv.funct. in pres.of sev.impairm./long
   717377-001: 40 mg, 30, R206,91  720358-001: 20 mg, 30, R166,00  term treatm. & discont. if elev., restrict.to pts.requir. contin. NSAID
   Dosage: Swallow whole. Recomm.dly dos.in morn. bef./dur.breakf.  Dosage: Admin.in morn. Swall.whole without chew./crush.  treatm.for prev.of NSAID induc. les., poss. cyanocobalam malabsorpt.
   Duod.ulc: 40 mg once dly. Total per.with IV & oral treatm: 2-4 wks.   Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm: 40 mg   with prolong. treatm. (ie.&gt;3 yrs.).
   Use in combinat.with appropr. antibiot.when assoc.with H.Pylori.  dly.may be effect. H pylori-posit. duod.ulc: Indic.as part of eradicat.   Drug interactions: Poss.interact.with other meds. also metabol.
   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  program. with appropr.antibiot.  by cytochrome P450 enzyme syst., poss.changes in absorpt.of pH-
   Zollinger-Ellison Syndr: Init.80 mg dly.thereaft. titrat. up/down as   Gastric ulc.& reflux oesophagit: 20 mg dly.x4-8 wks. When re-  depend. meds. eg.ketoconazole, atazanavir bioavail. substant. reduc.
   necess. Admin.dly.dos above 80 mg in 2 div.dos.  fract.to other treatm.regimens 40 mg once dly.may be effect. May   LANCAP, Pharma Dynamics [P/S]
   Contraindications: Safety & effic.in pregn.& lactat.& in childr.not   be contin.with 20 mg once dly in case of sev.or symptom.recurr.   Lansoprazole
   est., sev.liv.funct.impairm., concom. atazanavir.  reflux oesophagit.  Indications: (S4) 30 mg: Short-term treatm.of gastric/ duod. ulc. &
   Side effects: Bld.dyscras., GI disturbs., thrombophlebit.(IV), periph.  Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long   reflux oesophagit. 15 mg: Short-term managem.of mild funct.dys-
   oed., jaund.with/ without hepat.fail., anaphylax., incr.liv.enzym./   as clinic.reqd. Sev.dis.maint: Usual. 20-120 mg dly. Div.dos. &   peps., gastro-oesophag. reflux relapse prophylax. In conjunct.with ap-
   triglycer., incr.body temp., arthralg., myalg., headache, dizzin., vis.  admin.2xdly if above 80 mg dly.  propr. antibiot.as part of eradicat. program.for H.Pylori-posit.duod.ulc.
   disturbs., ment.depress., interstit. nephrit., allerg.reacts., sev.skin   NSAID-assoc.gastr. & duod.ulc: 20 mg once dly. x4wks. Contin.  (S2) 15 mg: Short term symptomat.heartburn & hyperacidity at
   reacts. incl.Stev. Johns./Lyell syndr./erythema multiforme, photosens.  for furth.4 wks.if heal.not compl.  max.15 mg dly dos.for max. 14 days.
   Special precautions: Concom.anticoags., not to exceed 20 mg dly   Contraindications: Safety in pregn./lactat.not est., concom. nelfi-  (S4) & (S2) CAPS, 40/11.4.3/0247, 0248
   in mild-mod.liv.impairm., monit. liv. funct. reg.in pres.of sev.impairm.  navir/atazanavir./indinavir.  715812-001: 15 mg, 14, R55,17
   esp.dur. longt.ther.& discont.if elev., not indicat.for min.GI compl., excl.  Side effects: Headache, dizzin., CNS effs., vertigo, depress., hal-  708052-001: 15 mg, 30, R118,22
   poss.malign., confirm reflux. oesophag. diagn.by endoscopy, poss. cy-  lucinat., GI /taste disturbs., stomatit., GI candidias., incr.liv.enzym.,   708053-001: 30 mg, 30, R166,15
   anocobalam malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.), long-term   encephalopathy with pre-exist.sev.liv.dis., hepatit., hepat.fail., skin   Dosage: Take bef.meals. Admin.low.dos.& short. durat.appropr.
   treatm.exper.limit., IVI & tabs.cont.mannitol  reacts.incl.erythema multiforme/ Stev.-Johns. syndr./tox.epiderm.  to condit.treat.
   Drug interactions: Reduc./incr.absorpt.of pH-depend.meds.eg. ke-  necrolys., alopec., bld. dyscras., platel./bleed.& clott.disords., gy-  Heartburn & hyperacidity: 15 mg dly.for up to max.14 days.
   toconazole, poss.interacts. with meds.also metabol.via cytochrome   naecomast., arthralg., myalg., musc.weakn., arthrit., UTI, interstit.  Gastr.ulc: 30 mg once dly.for up to 8 wks.
   P450 enzyme syst.            nephrit., malaise, incr.sweat., periph. oed., back/chest pain, hy-  Duod.ulc: 30 mg once dly.for up to 4 wks. As part of eradicat.pro-
                                persens., angioed., fev., bronchosp., anaphylact.shock, URTI, blurr.  gram.with appropr. antibiot.for H.pylori posit.ulc.
   BURNLOC, AI Pharm [P/S]      vis., hyponatraem., proteinur., hypomagnesaem., hypocalcaem.,   Oesophagit.due to gastro-oesophag.reflux: 30 mg once dly.x4
   Lansoprazole                 hypokalaem.                   wks., rep.4 wk.course poss. necess.
   Indications: Short-term managem.of mild funct. dyspeps.& gastro-  Warnings and special precautions: Not indic. for mild GI com-  Gastro-oesophageal reflux prevent: Maint: 15 mg once dly.
   oesophag.reflux relapse prophylax.  pl.such as nerv.dyspeps., excl.poss. malign., cons.risk vs.benef.in   for max.1 yr.
   (S4) CAPS, A39/11.4.3/0116   chron.hepat.dis.or hist. thereof, lact.intol., concom.warfar./ pheny-  Funct.dyspeps: Adults: 15-30 mg once dly.x2-4 wks.
   707192-003: 15 mg, 7, R27,46  toin/ digoxin/indinavir, sev.hepat.impairm., excret. in breast milk,   Elderly: Max.dly.dos: 30 mg.
   707192-001: 15 mg, 14, R54,91  gastr.glandul.cysts dur. longt.ther., incr.osteoporos.-relat.fract.risk,   Contraindications: Pregn.& lactat., liv. impairm., safety & effic.in
   Dosage: Admin.bef.meals. Paed.use not studied.  hypergastrinaem.may be high.in pts.with H.pylori infect., incr.GI   childr.not est., lact. intol.
   Gastro-oesophag.reflux maint.prophylax: 15 mg once dly.  Salmonella/Campylobacter/ Shigella/ Clostrid.diffic.infect.risk, cya-  Side effects: CNS effs., bld.dyscras., oed., headache, dizzin., tremor,
   x1 yr.max.                   nocobalamin absorpt. reduct., potent.vit.defic.risk with longt.t her.,   GI disturbs. incl. ulcerat. colit., gynaecomast., galactorrh., elev. hepat.
   Funct.dyspeps: 15-30 mg dly.x2-4 wks.  fat malabsorpt., limit.exper.in childr., longt. safety in pts.with ren.&   enzym., asthen., arthralg., myalg., blurr. vis., skin reacts., alopec., fev.,
   Contraindications: Pregn.& lactat., liv.impairm., safety & effic.  hepat.impairm.not est., cirrhos., gastr.polyps with dly.ther.for 1 yr.,   incr.freq.of gastr. glandul.cysts.dur long term treatm.& incr.gastr. bact.
   in childr.not est.           elderly pts. receiv.high dos.  counts result.from inhib.of gastr.acid secret. incr.GIT infects.risk.
   Side effects: Bld.dyscras., oed., CNS effs., GI disturbs.incl.ulcerat.  Drug interactions: Alter.absorpt.of some meds., poss. prolong.  Special precautions: Pass.into milk of rats, tumorigen.effs.in anim.,
   colit., gynaecomast., galactorrh., elev.hepat.enzymes, asthen., ar-  eliminat.of diazepam/warfar.or other Vit. K antagon./ phenytoin/  excl.malign., incr. Clostrid. diffic.assoc.diarrh.risk, monit. concom. war-
   thralg., myalg., blurr.vis., skin reacts., fev., incr.freq.of gastr. glandul.  meds.metabol.by oxidat. in liv., plasma conc.of both meds.incr.with   far., confirm reflux.oesophagit.diagnos.by endoscopy.
   cysts.dur long term treatm.& incr. gastric.bact.counts result.from in-  voriconazole, decr.atazanavir/indinavir/nelfinavir, incr. expos.with   Drug interactions: Sedat.eff.potent.by CNS depress. & alcoh.,
   hibit.of gastr. acid secret.  flovoxamine, clopidogrel antiplatel. eff.reduc.in pts.tak.clopidogrel &   poss.interacts.with drugs metabol. by cytochrome P450 syst., war-
   Special precautions: Excl.malign., confirm. diagnos. by endoscopy,   aspir. or clopidogrel alone, poss.interacts.with meds.also metabol. via   far.conc. poss.reduc.
   monit.concom.warfar.         cytochrome P450 enzyme syst., concom. clarithromycin poss.incr.plas-
   Drug interactions: CNS depress.eff.enhanc.by CNS depress.& al-  ma conc.of both drugs., digox.bioavailabil.incr., diet.Vit.C bioavail. imp.  LANSOLOC, Cipla Medpro [P/S]
   coh., poss.interacts.with drugs metabol. by cytochrome P450 syst.,   Lansoprazole.
   warfar.conc. poss.reduc.     GASTRIWIN, (Zentiva) Takeda [P/S]  Indications: Short-term treatm.duod., gastr.ulc., & reflux oe-
                                Pantoprazole.                 sophagit., with appropr.antibiotics in H.Pylori positive duod.ulc.
   CONORAN, Ranbaxy [P/S]       Indications: 40 & IV: Short-term treatm.of duod.& gastr. ulc., re-  (S4) CAPS. 37/11.4.3/0155
   Pantoprazole.                flux oesophagit., duod.ulc. assoc.with H.pylori infect.in combinat.  704754-001: 30 mg, 30, R261,55
   Indications: 40 mg tabs: Short-term treatm.of duod./gastr.ulc.&   with appropr.antibiot., Zollinger-Ellison syndr. Inj: Also when oral   Dosage: Admin.bef.meals. Use in childr.not studied.
   reflux oesophagit., use in combinat. with appropr.antibiot., Zollinger-  ther.not suitable.  Gastr.ulc: 30 mg dly x8 wks.
   Ellison syndr.               20: Symptomat.improvem.& heal.of mild gastro-oesophag.reflux   Duod.ulc: 30 mg dly upto 4 wks. May be used as part of eradi-
   20 mg tabs: Mild gastro-oesophag.reflux dis (GORD) & the long term   dis., on demand regimen for recur. sympts.of heal.reflux dis., long   cat.programm.with appropr.antibiot. in H Pylori positive duod.ulc.
   managem.& relapse prevent. thereof, prevent.of gastroduod.les.&   term managem. & prev.relapse in gastro-oesophag. reflux dis., prev.  Oesophagit.due to gastro-oesophag.reflux: 30 mg dly x4 wks.,
   dyspept.sympts.induc.by NSAID’s.  of NSAID induc.gastroduod.les.& dyspept.sympts.in at risk pts.  rep.for furth.4 wks.depend.on endoscopic results.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page210.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page206.html">206</a>&nbsp;&nbsp;&nbsp;<a href="page207.html">207</a>&nbsp;&nbsp;&nbsp;<a href="page208.html">208</a>&nbsp;&nbsp;&nbsp;<a href="page209.html">209</a>&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>
             </td>
             <td width="35%"><a href="page212.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page212.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
